Effect of tumor size on prognosis in patients treated with radical radiotherapy or chemoradiotherapy for non-small cell lung cancer: An analysis of the staging project database of the international association for the study of lung cancer

Journal of Thoracic Oncology

Volumn 8, Issue 3, 2013, Pages 315-321

  Ball, David ^a,b   Mitchell, Alan ^c   Giroux, Dori ^c   Rami Porta, Ramon ^d,e  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c Fred Hutchinson Cancer Research Center   (United States)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Metastasis stage; Node; Non small cell lung cancer; Prognosis; Radiotherapy; Tumor; Tumor size

Indexed keywords

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; RADIATION DOSE; WEIGHT REDUCTION;

EID: 84874113650     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31827dc74d     Document Type: Article

References (10)

1. Rami-Porta R, Ball D, Crowley J, et al.; International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2007;2: 593-602.
2. Basaki K, Abe Y, Aoki M, Kondo H, Hatayama Y, Nakaji S. Prognostic factors for survival in stage III non-small-cell lung cancer treated with definitive radiation therapy: impact of tumor volume. Int J Radiat Oncol Biol Phys 2006;64: 449-454.
3. Bradley JD, Ieumwananonthachai N, Purdy JA, et al. Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys 2002;52: 49-57.
4. Dehing-Oberije C, De Ruysscher D, van der Weide H, et al. Tumor volume combined with number of positive lymph node stations is a more important prognostic factor than TNM stage for survival of non-smallcell lung cancer patients treated with (chemo)radiotherapy. Int J Rad Oncol Biol Phys. 2008;70: 1039-44.
5. Etiz D, Marks LB, Zhou S-M, et al. Influence of tumor volume on survival in patients irradiated for non-small-cell lung cancer. Int J Rad Oncol Biol Phys. 2002;53: 835-46.
6. Stinchcombe TE, Morris DE, Moore DT, et al. Post-chemotherapy gross tumor volume is predictive of survival in patients with stage III non-small cell lung cancer treated with combined modality therapy. Lung Cancer 2006;52: 67-74.
7. Dubben HH, Thames HD, Beck-Bornholdt HP. Tumor volume: a basic and specific response predictor in radiotherapy. Radiother Oncol 1998;47: 167-174.
8. Goldstraw P, Crowley J. The International Association for the Study of Lung Cancer International Staging Project on Lung Cancer. J Thorac Oncol. 2006;1: 281-6.
9. Rusch VW, Crowley J, Giroux DJ, et al.; International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2007;2: 603-612.
10. James K, Eisenhauer E, Christian M, et al. Measuring response in solid tumors: unidimensional versus bidimensional measurement. J Natl Cancer Inst 1999;91: 523-528.